Quantitative Sensory Testing and Central Sensitization in Endometriosis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Endometriosis is a gynecologic condition where there is growth of endometrial-like tissue outside the uterus, leading to severe pelvic pain. Despite conventional treatment, many patients experience persistent pelvic pain due to central sensitization (CS), where the central nervous system amplifies pain signals. Quantitative Sensory Testing (QST) enables objective testing of CS. However, there are several patient-reported questionnaires that have shown promising potential as subjective proxies of CS. Therefore, in this study, our objective is to validate six patient-reported questionnaires as measures of CS by comparing them to each other and determining whether each questionnaire correlates with QST thresholds.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 19
Maximum Age: 49
View:

• New or re-referral appointment at the BC Women's Centre for Pelvic Pain and Endometriosis.

• Consented to be contacted for future research in the centre data registry (EPPIC NCT02911090; H16-00264).

• Surgically confirmed endometriosis, current imaging diagnosis, or current clinically suspected endometriosis diagnosed at the new or re-referral appointment as coded in the registry.

• 19 to 49 years old.

• Willing and committed to completing six questionnaires about pain.

⁃ QST specific criteria

⁃ • Willing and committed to QST testing.

Locations
Other Locations
Canada
BC Women's Hospital + Health Centre
RECRUITING
Vancouver
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2026-01-31
Participants
Target number of participants: 90
Related Therapeutic Areas
Sponsors
Collaborators: University of British Columbia
Leads: BC Women's Hospital & Health Centre

This content was sourced from clinicaltrials.gov